Mercola: How Did Carcinogenic Generic Pill Get Past the FDA?

Analysis by Dr. Joseph MercolaFact Checked

  • December 01, 2021

PreviousView More World Record Holder Has Heart Damaged by VaccineView More

ndma in generic pills

STORY AT-A-GLANCE

  • Since 2018, the carcinogenic compound NDMA has been found in several different drugs, including three blood pressure medications (valsartan, losartan and irbesartan), two heartburn medications (Zantac and Axid) and the diabetes drug metformin
  • In the case of valsartan, three companies whose drugs were recalled in 2018 had all purchased the active ingredient from a Chinese manufacturer called Zhejiang Huahai Pharmaceutical Co.
  • The U.S. Food and Drug Administration checks less than 1% of imported drugs for impurities or potency, and in five years sent warning letters to only 25% of companies suspected of faking quality data
  • While generics are a boon to patients in that they’re far less expensive while still providing the same benefits, there’s more room for error as they also receive far less scrutiny by regulators, and manufacturers are trusted to regulate themselves
  • An estimated 80% of all active drug ingredients are manufactured in China and India, and overseas plants are rarely inspected by U.S. authorities

This article was previously published September 30, 2020, and has been updated with new information.

full article

Unknown's avatar

About michael burgwin

A child of the peace and antiWar movements, a Truther with self-diagnosed Opposition Defiance Disorder, formerly politically liberal tho now politically marooned, and Post-Doomer, on any issue, I trend to the conspiracy side, sort through the absurd, fantastical and insane, until I find firm ground usually located just the other side of the censorship firewall of propaganda and orthodoxy, dogma, and other either / or thinking.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a comment